Scientists Discover Origin of Malaria
... chimps that had died due to anthrax, respiratory disease
or other reasons in the Tai National Park. ... Amherst.
"It is now clear that a new disease
that successfully jumps from an animal to a human ... said. "This makes the task of stopping future disease
spillovers from animals to humans vital, not only ...
Shire Reports Positive Results From First of Three Phase III Trials of velaglucerase alfa for Type 1 Gaucher Disease and Provides Important Updates on Interactions With FDA
Background on Gaucher disease
is an autosomal recessive disease
and the most prevalent
Lysosomal Storage Disorder ...
Online H1N1 Management: FairChoice Helps Schools Respond to Infectious Disease on Campus
... campus health officers to alert students about disease
prevention, monitor the spread of infection, and ... to distribute information about meningococcal disease
and vaccination to students. Since its ... have certified their receipt of meningococcal disease
information online, according to the Columbia ...
VisEn Molecular Imaging Technology Enables Key Insights Into Newly Discovered Biologic Pathway Published in SCIENCE
... potentially advance therapeutic approaches to key disease
areas including inflammation and myocardial ... of the recruited splenic monocytes at the disease
site, thus helping to confirm "unambiguously the ... characterizing and quantifying ranges of disease
biomarkers and therapeutic efficacy in vivo . ...
Study Shows Cancer Vaccines Led to Long-Term Survival for Patients with Metastatic Melanoma and to Long Periods of Disease Control After Completion of Therapy
... rates in patients with metastatic melanoma whose disease
had been minimized by other therapies.
... patients with recurrent or distant metastatic disease
at the time of diagnosis because there are no ... therapy, even though they had widely metastatic disease
and/or repeated appearance of new metastases ...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
... the number of women suffering from the disease
is predicted to increase in Ohio by more than 22 ... osteoporosis are not optimally managing their disease
despite the need and desire to work longer, ... half of the women with PMO are fearful that the disease
will limit their ability to work. However, the ...
Dirucotide Does Not Meet Primary Endpoint in Phase III MAESTRO-01 Trial in Secondary Progressive Multiple Sclerosis
... did not meet the primary endpoint of delaying disease
progression, as measured by the Expanded ... (MS) is a chronic, progressive, often disabling disease
that attacks the central nervous system(ii). MS ... 400,000 in the United States(v). It is a disease
that affects more women than men, with onset ...
R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies - Results Incongruent
... physician and patient global assessment of disease
activity, patient reported pain score, and any ... people in the U.S. It is a chronic inflammatory disease
that puts the body's immune system into overdrive ... pathways and related targets that are critical to disease
mechanisms. Rigel's productivity has resulted in ...
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
... knockout rats to gain a better understanding of disease
processes related to hypertension, heart disease, ... pharmaceutical development, the diagnosis of disease
and as key components in pharmaceutical and other ... neuropathic pain, nerve regeneration, Parkinson's disease
and monogenic diseases. Sangamo's core ...
Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
... for asthma and chronic obstructive pulmonary disease
(COPD) medications, in terms of dollar sales (1). ... About Asthma
Asthma is a chronic lung disease
characterized by inflammation of the air ... and costly chronic diseases.(2) Annually, this disease
leads to almost two million asthma-related ...
Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study
... Diabetes is the fifth leading cause of death by disease
in the U.S. and results in approximately $174 ...
According to the Centers for disease
Control and Prevention's National Health and ... CC. "Poor control of risk factors for vascular disease
among adults with previously diagnosed diabetes." ...
Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival
... to address waxing and waning progression of disease
FREMONT, Calif., July 20 ... of race/ethnicity, or the stage of their disease
when diagnosed. The study results were published ... a continuing care program. The nature of the disease
could make it difficult for people who may not be ...
Cardax Pharmaceuticals Nominates Clinical Candidate Heptax for Liver Disease; Heptax Ameliorates Inflammation and Oxidative Stress Related to Liver Disease and Metabolic Syndrome
... Hawaii, July 20 /PRNewswire/ -- The Centers for disease
Control and Prevention reported this week that ... syndrome, including liver and cardiovascular disease
as well as diabetes. Preclinical animal studies ... for the treatment of liver and cardiovascular disease
as well as metabolic syndrome."
First Potential Lupus-Specific Treatment in Sight
... treated with BENLYSTA had improvement in overall disease
activity without clinically significant flare-ups ... provide hope that this complex chronic autoimmune disease
can be brought under control and that, ... developed to specifically treat lupus since the disease
was discovered more than a century ago.
Lupus Research Institute Highly Encouraged by Benlysta(TM) Trial Results
... that enables researchers to demonstrate disease
improvement. This will benefit lupus patients and ... currently used treatments are as toxic as the disease
itself. Lupus is a leading cause of premature cardiovascular disease, kidney disease
and stroke among young women.
Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
... effect on both patients living with the disease
and their families," said Carlo Russo, M.D., ... BENLYSTA also significantly reduced SLE disease
activity versus placebo based on a number of ... of at least 4 points on the SELENA SLEDAI disease
activity scale (which indicates a clinically ...
Cognition Therapeutics Closes Series A Financing to Advance Drug Candidates for Alzheimer's Disease
... approach to treat or prevent Alzheimer's disease
by targeting the proteins that cause the earliest ... senior advisor to Ogden CAP. "Alzheimer's disease
is a major health epidemic that places increasing ... disease," Gailus continued. Alzheimer's disease
affects an estimated four and a half million ...
Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
... accepted would allow
physicians to treat Gaucher disease
patients with velaglucerase alfa on an
early ... pattern.
Background on Gaucher disease
is an autosomal ...
Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease
... a source of worry for many who fear Alzheimer's disease
. Now a new Mayo Clinic-led study published in ... of a common genetic risk factor for Alzheimer's disease
begin to have memory declines in their mid-50s, ... genetic risk factor for developing Alzheimer's disease
at older ages. Each additional copy of this gene ...
Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference
... epidemic of the 21st century -- Alzheimer's disease
-- at the Alzheimer's Association 2009 International Conference on Alzheimer's disease
(ICAD 2009) in Vienna, Austria.
(Logo: ... mild to moderate Alzheimer's by the Alzheimer's disease
Cooperative Study (ADCS) supported by the U.S. ...
Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets
... pathway, as a target for Parkinson ' s disease
Yoon-Seong Kim, MD, PhD, Weill ... strategy for the t reatment of Parkinson's disease
Deniz Kirik, MD, PhD, Lund University ... as therapeutic targets for Parkinson ' s disease
Hilal A. Lashuel, PhD, and Patrick ...
deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke
health challenges from cardiovascular disease
to cancer. Based upon these
discoveries deCODE ... with
therapeutic applications in Alzheimer's disease
and other conditions. deCODE
is delivering on the ... personal genome analysis
service and new focused disease
scans, integrating the genetic variants
PTSD Associated With Higher Alzheimer's/Dementia Risk; Moderate Alcohol Consumption May Lower it
... -- Though discoveries about Alzheimer's disease
risk factors are often in the news, adults do not know about the relationship between Alzheimer's disease
risk and heart health, nor that physical activity ... 2009 International Conference on Alzheimer's disease
(ICAD 2009) in Vienna.
Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline
... 2009 International Conference on Alzheimer's disease
(ICAD 2009) in Vienna.
(Logo: ... of the trials was conducted by the Alzheimer's disease
Cooperative Study (ADCS) supported by the ... for Alzheimer's must be given very early in the disease
for them to be truly effective," said William ...
CEL-SCI to Present Data from Multikine Clinical Trials at National Institutes of Health (NIH), National Cancer Institute (NCI) Seminar Series
... that Multikine treatment provides for early disease
management in newly diagnosed (treatment naive) ... of the Head and Neck. Early intervention in this disease
is seen by many clinicians and researchers in the field as a key to improving disease
outcome in these patients.
Dr. Talor will ...
Rigel's R788 Significantly Improves Rheumatoid Arthritis in Phase 2b Clinical Trial
... a treatment
failure (ACR non-responder). disease
Activity Scores are based on a 28
joint ... physician and patient global assessment of disease
activity, patient reported pain score, and any ... the ACR 20, ACR 50 and ACR 70 scores, as well as disease
Activity Scores (DAS) over the period of 6 ....
Thiarabine Demonstrates a Reduction of Both Inflammatory and Erosive Disease Parameters in Rheumatoid Arthritis
... treatment resulted in a broad inhibition of disease
pathology, with reduction of both inflammatory and erosive disease
parameters, as well as protection from loss of ... thiarabine blocked the development of joint disease
at the 60 mg/kg/day dose level and exhibited a ...
Clay Walker's Band Against MS Foundation Donates $150,000 To Support Multiple Sclerosis Research
... The money will fund important studies on the disease
and potential cures at the University of Texas ... also to the millions of people who live with the disease
on a daily basis," said Dr. Wolinsky. "We are ... he wanted to help others living with the same disease
he has battled since 1996. More information about ...
Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
... approved and marketed treatment for
patients, it has filed a treatment protocol for ... protocol would allow physicians to
treat Gaucher disease
patients with velaglucerase alfa ahead of ... alfa as an alternative choice for Gaucher disease
Background on ...
Number of Patients With Dementia on the Rise
... Sid Gilman, M.D., director of the Alzheimer's disease
Research Center at University of Michigan ... and others in her community. "It's a horrible disease
that robs people of their humanity. They forget ... the current number of patients with Alzheimer's disease
in the United States is roughly 5 million. By the ...
deCODE-led Megastudy Finds New Genetic Clues to Causes of Schizophrenia
... are crucial for teasing out the
biology of the disease
and making it possible for us to begin to ... with therapeutic
applications in Alzheimer's disease
and other conditions. deCODE is a global
leader ... public health challenges from
to cancer. Based upon these discoveries deCODE ...
MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants
... regions established by the U.S. Centers for disease
Control & Prevention. Additionally, this ... prematurely as well as those with chronic lung disease
(CLD) or congenital heart disease
(CHD) are at highest risk for ...
SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
... itself on being a leading provider of rheumatic disease
therapies within the European rheumatology ... arthritis is a chronic and debilitating disease
that affects more than three million people in ... arthritis, AS is a systemic inflammatory disease
that, in addition to its effect on the spine, can ...
MJFF's Rapid Response Innovation Awards Hit Mid-2009 With Over $1 Million Funded in High-Risk/High-Reward Approaches to Parkinson's Disease
... and efficacy of an FDA-approved drug for kidney disease
to treat Parkinson's; characterization of a ... for determining whether phenylbutyrate may slow disease
Richard Smeyne, PhD, of ... outbreak of 1918, documenting Parkinson's disease
following exposure to flu virus. The researchers ...
ThromboGenics' Microplasmin Phase III Program Progressing According to Schedule
... Product for the
Non-Surgical Treatment of Eye disease
With No Reported Safety Issues
... innovative treatments for eye
disease, vascular disease
and cancer, announces today that its lead ... difference
to the treatment of back of the eye disease
and we very much look forward to
reporting the ...
ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing and Whitepaper Availability on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Diseases
... drug treatment for non-alcoholic fatty liver disease
Over 60 million adult Americans ... membranes are expected to be a rich source of disease
state biomarkers. Nanoveson(TM) also has the ... therapeutic impact on arachidonic acid driven disease
states by reducing arachidonic acid availability ...
Spherix Announces Positive Phase 2 Study Results
Type 2 diabetes mellitus (T2DM) is a disease
that is characterized by elevated blood glucose ... medications are usually needed as the disease
progresses. There are an estimated 23.6 million ... increase as an epidemic. Customarily considered a disease
of adults, T2DM is increasingly being diagnosed ...
Conatus Pharmaceuticals Initiates a Second Phase 2 Clinical Trial for the Treatment of Hepatitis
... a novel drug candidate for the treatment of liver disease
associated with Hepatitis C Virus (HCV) ... multiple preclinical models of inflammatory liver disease
and HCV infection.
The clinical trial is a ... represents a novel approach to treating HCV disease
and look forward to developing this drug ...
New Therapy Found to Prevent Heart Failure
... in heart failure or death in patients with heart disease
who received an implanted cardiac ... were very positive.
Patients with heart disease
have a risk of arrhythmias and heart failure. The ... is a very large population of patients with heart disease
who will benefit from this combined therapy."
GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
... condoms. It is obvious from the spread of the disease
that these methods are not adequate. Existing ... people to prevent Acquired Immunodeficiency disease
(AIDS), caused by the virus known as HIV-1, ... Institutes of Health (NIH), The Centers for disease
Control and Prevention (CDC) and GeoVax.